The Valley Desk

ArticleJournal of the American Heart AssociationPublished

Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
Journal of the American Heart Association
Published
Subject terms
Humans; Atrial Fibrillation; Embolism; Hemorrhage; Pyrazoles; Pyridones; Treatment Outcome; Risk Factors; Retrospective Studies; Aged; Aged, 80 and over; Middle Aged
PubMed ID
41553085
PubMed Central ID
PMC12919467
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal